Premium
IC‐P‐098: In vitro Characterization of MK‐3328: A Novel Fluorinated Positron Emission Tomography Tracer for Plaques
Author(s) -
Sur Cyrille,
Zeng Zhizhen,
Hostetler Eric,
Connolly Brett M.,
Miller Patricia J.,
O'Malley Stacey,
Chen Tsin-Bau,
Culberson Christopher,
Harrison Scott,
Mulhearn Jim,
Wolkenberg Scott,
Barrow James,
Sanabria Sandra,
Cook Jacquelynn J.,
Hargreaves Richard,
Williams David L.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.112
Subject(s) - monoamine oxidase , in vitro , positron emission tomography , human brain , enzyme , chemistry , in vivo , biochemistry , medicine , nuclear medicine , biology , psychiatry , microbiology and biotechnology
IC-P-098 IN VITRO CHARACTERIZATION OF MK-3328: A NOVEL FLUORINATED POSITRON EMISSION TOMOGRAPHY TRACER FOR BETA-AMYLOID PLAQUES Cyrille Sur, Zhizhen Zeng, Eric Hostetler, Brett M. Connolly, Patricia J. Miller, Stacey O’Malley, Tsin-Bau Chen, Christopher Culberson, Scott Harrison, Jim Mulhearn, Scott Wolkenberg, James Barrow, Sandra Sanabria, Jacquelynn J. Cook, Richard Hargreaves, David L. Williams, Imaging Merck and Co Inc., West Point, PA, USA; Medicinal Chemistry Merck and Co Inc., West Point, PA, USA; Neuroscience Franchise Merck and Co Inc, West Point, PA, USA. Contact e-mail: cyrille_sur@merck.com